Why Aseptic Fill Finish is Complicated

 

When a drug product, container, and closure are treated to sterilization processes separately before being brought together, this is known as aseptic production and sterile fill finish (aseptic manufacturing). Containers must be filled and sealed in an exceedingly controlled environment due to the lack of a mechanism to sterilize the product in its final container (drug fill finish). This is one of the most difficult challenges in the pharmaceutical manufacturing industry.

Aseptic processing is complicated since it necessitates meticulous planning, extensively trained employees with the necessary mindset, and specialized facilities, equipment, and processes to be carried out correctly. Maintaining sterility is not a simple undertaking, and failure to do so can have catastrophic—even life-threatening—repercussions on a patient's health. The final goal of an aseptic production process is to eliminate the potential for contamination, whether from microbes or particulates that could hurt a patient if they were to be delivered to them.

Any of the following can be causes of contamination in an aseptic processing and sterile fill-finish operation:

1. Facilities for Cleanrooms
2. Processes and Equipment
3. Components of Drug Products

The attainment of aseptic processing and sterile fill-finish processes is dependent on the ability to mitigate contamination from each of these sources individually.

1. Facilities for Cleanrooms

Aseptic processing and sterile fill-finish procedures take place in cleanrooms that are specifically built to manage the flow of employees, materials, and equipment during a manufacturing process. A cleanroom is a sterile environment with strict controls over worker access, contamination levels, pressurization, and temperature/humidity. Multiple rooms with differing degrees of control compose the cleanroom suite. This is a "cascading" design in which the air quality improves as you approach the facility's aseptic center (a Class 100 space). Personnel, materials, and equipment begin in support areas that allow growing, non sterile preparation, and formulation activities.

2. Equipment and Process

Sterile fill-finish operations can take numerous forms, including hand-filling of clinical trial material (CTM), completely automated high-speed filling lines, and sterile lyophilization, to mention few. This section will focus on solution filling of glass vials and syringes, which is conducted with semi-automated or fully-automated fillers

Process design for aseptic manufacturing concentrates on minimizing exposure of sterile goods to contamination hazards. This means that operations should flow logically, and equipment should be positioned to reduce redundant activities and movement by workers. Because interventions by employees can raise the danger of contamination, sterile fill-finish equipment is frequently built to minimize the requirement for human engagement. Many vial and syringe fillers come integrated with in-line weight monitoring, allowing operators to monitor the weight of products without handling the drug product. Fillers may also have automatic rejection and vision systems to sort and process vials and syringes as they are filled. Sterilize-In-Place (SIP) technology sterilizes equipment without complex manipulations and aseptic connections between process components.

3. Components of Drug Products

When the word "sterile fill-finish" is mentioned, the first thing that comes to mind is sterile injectables (e.g., liquids filled in vials or syringes). While fluid solutions, suspensions, and emulsions are typical for sterile fill finish processes, powder fills, and lyophilization (freeze-drying to maintain and increase stability) are also done under aseptic circumstances.